
Regenxbio: Flat Price Response To Key Catalysts Confirms Hold (NASDAQ:RGNX)
kyoshino Investment Summary Now that we’re well into the new year we continue to advise on underexploited names working to provide medical breakthroughs in complex disease segments. Following a deep dive on Duchenne muscular dystrophy […]